- £420.19m
- £457.13m
- £72.43m
- 61
- 42
- 91
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 85.5 | 70 | 110 | 167 | 72.4 |
Cost of Revenue | |||||
Gross Profit | 27.9 | 10.6 | 48.7 | 83.4 | 12.3 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 61.2 | 42.2 | -12 | 122 | 18.2 |
Operating Profit | 24.3 | 27.8 | 122 | 44.5 | 54.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 30.3 | 33.3 | 127 | 30.9 | 49.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25.5 | 25.8 | 94 | 27.8 | 38 |
Net Income Before Extraordinary Items | |||||
Net Income | 25.5 | 25.8 | 94 | 27.8 | 38 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 25.5 | 25.8 | 94 | 27.8 | 38 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.071 | 0.073 | 0.276 | 0.079 | 0.117 |
Dividends per Share |